Dr Ruth Wong

All publications

Journal articles

• Campbell F, Wong R, Llewellyen JL, Stoniute A, Pearson F & Bond M (2024) PROTOCOL: Methods used in the development, production and updating of evidence and gap maps: A scoping review. Campbell Systematic Reviews, 20(2), e1402.
• Borrelli S, Ramasamy R, Wong R & Spiby H (2023) Care and support during maternity for mothers affected by modern slavery: A scoping review. International Journal of Nursing Studies Advances, 5, 100139-100139.
• Thokala P, Srivastava T, Smith R, Ren S, Whittington MD, Elvidge J, Wong R & Uttley L (2023) Living health technology assessment: issues, challenges and opportunities. PharmacoEconomics, 41(3), 227-237.
• Henstock L, Wong R, Tsuchiya A & Spencer A (2022) Behavioral theories that have influenced the way health state preferences are elicited and interpreted: a bibliometric mapping analysis of the time trade-off method with VOSviewer visualization. Frontiers in Health Services, 2. View this article in WRRO
• Spencer A, Rivero-Arias O, Wong R, Tsuchiya A, Bleichrodt H, Edward RT, Norman R, Lloyd A & Clarke P (2021) The QALY at 50 : one story many voices. Social Science & Medicine.
• Duarte A, Walker S, Metry A, Wong R, Panovska-Griffiths J & Sculpher M (2021) Jointly modelling economics and epidemiology to support public policy decisions for the COVID-19 response : a review of UK studies. PharmacoEconomics, 39(8), 879-887. View this article in WRRO
• Rowen D, Keetharuth D, Poku E, Wong R, Pennington R & Wailoo A (2020) A review of the psychometric performance of selected child and adolescent preference-based measures used to produce utilities for child and adolescent health. Value in Health. View this article in WRRO
• Martyn‐St James M, Faria R, Wong R & Scope A (2020) Evidence for the impact of interventions and medicines reconciliation on problematic polypharmacy in the UK: a rapid review of systematic reviews. British Journal of Clinical Pharmacology. View this article in WRRO
• Hill J, Pennington R, Wailoo A, Wong R & Rowen D (2020) A review of the methods used to generate utility values in NICE technology assessments for children and adolescents. Value in Health. View this article in WRRO
• Thapa S, Wong R & Goodacre S (2020) Implementation of rapid rule out of myocardial infarction using high-sensitivity troponin : cross-sectional survey of English hospitals. Emergency Medicine Journal. View this article in WRRO
• Uttley L, Carroll C, Wong R, Hilton DA & Stevenson M (2020) Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. The Lancet Infectious Diseases, 20(1), e2-e10. View this article in WRRO
• Rutter MD, East J, Rees CJ, Cripps N, Docherty J, Dolwani S, Kaye PV, Monahan KJ, Novelli MR, Plumb A , Saunders BP et al (2019) British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut, 69(2), 201-223. View this article in WRRO
• Alshreef A, Latimer N, Tappenden P, Wong R, Hughes D, Fotheringham J & Dixon S (2019) Statistical methods for adjusting estimates of treatment effectiveness for patient nonadherence in the context of time-to-event outcomes and health technology assessment: A systematic review of methodological papers. Medical Decision Making, 39(8), 910-925. View this article in WRRO
• Pandor A, Kaltenthaler E, Martyn-St James M, Wong R, Cooper K, Dimairo M, O’Cathain A, Campbell F & Booth A (2019) Delphi consensus reached to produce a decision tool for SelecTing Approaches forRapid Reviews (STARR). Journal of Clinical Epidemiology, 114, 22-29. View this article in WRRO
• Harnan S, Tappenden P, Cooper K, Stevens J, Bessey A, Rafia R, Ward S, Wong R, Stein RC & Brown J (2019) Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Health Technology Assessment, 23(30), 1-328. View this article in WRRO
• Mukuria C, Rowen D, Harnan S, Rawdin A, Wong R, Ara R & Brazier J (2019) An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy, 17(3), 295-313. View this article in WRRO
• Tappenden P, Carroll C, Hamilton J, Kaltenthaler E, Wong R, Wadsley J, Moss L & Balasubramanian S (2019) Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health Technology Assessment, 23(8), 1-144. View this article in WRRO
• Squires H, Bermejo I, Poku EN, Cooper K, Stevens J, Hamilton J, Wong R, Denniston AK, Pearce I & Quhill FM (2019) Dexamethasone implant for non-infectious uveitis: is it cost-effective?. British Journal of Ophthalmology. View this article in WRRO
• Bermejo I, Squires H, Poku EN, Cooper K, Stevens JW, Hamilton J, Wong R, Pearce I, Quhill FM & Denniston AK (2019) Adalimumab for non-infectious uveitis: is it cost-effective?. British Journal of Ophthalmology. View this article in WRRO
• Tappenden P, Carroll C, Stevens J, Simpson E, Thokala P, Wong R, Wright J & Auer R (2019) Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 37(1), 7-18. View this article in WRRO
• Uttley L, Bermejo I, Ren S, Martyn-St James M, Wong R, Scott DL, Young A & Stevenson M (2018) Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(9), 1063-1072. View this article in WRRO
• Pandor A, Stevenson M, Stevens J, James MM-S, Hamilton J, Byrne J, Rudin C, Rawdin A & Wong R (2018) Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(8), 903-915. View this article in WRRO
• Ren S, Bermejo I, Simpson E, Wong R, Scott D, Young A & Stevenson M (2018) Baricitinib for previously treated moderate or severe rheumatoid arthritis: an evidence review group perspective of a NICE single technology appraisal . PharmacoEconomics, 36, 769-778. View this article in WRRO
• Stevenson M, Pandor A, Hamilton J, Stevens J, Rowntree C, Martyn-St James M, Rawdin A & Wong R (2018) Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(7), 759-768. View this article in WRRO
• Simpson EL, Hock E, Stevenson M, Wong R, Dracup N, Wailoo A, Conaghan PG, Estrach C, Edwards CJ & Wakefield RJ (2018) What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis. Health Technology Assessment, 22(20). View this article in WRRO
• Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M , Strong M et al (2018) Corrigendum: A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.. Health Technology Assessment, 20(78), 407-424. View this article in WRRO
• Wailoo A, Hock ES, Stevenson M, Martyn-St James M, Rawdin A, Simpson E, Wong R, Dracup N, Scott DL & Young A (2017) The clinical effectiveness and Cost-Effectiveness of Treat-To-Target strategies in rheumatoid arthritis: A systematic review and cost-effectiveness analysis. Health Technology Assessment, 21(71), 1-258. View this article in WRRO
• Squires HY, Poku E, Bermejo I, Cooper K, Stevens J, Hamilton J, Wong R, Denniston A, Pearce I & Quhill F (2017) A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate, posterior or panuveitis in adults. Health technology assessment, 21(68). View this article in WRRO
• Uttley L, Whyte S, Gomersall T, Ren S, Wong R, Chambers D & Tappenden P (2017) Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(7), 717-726. View this article in WRRO
• Tappenden P, Harnan S, Ren S, Thokala P, Wong R, Mukuria C, Green C, Pledge S & Tidy J (2017) Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(1), 97-109. View this article in WRRO
• Davis S, Martyn-St James M, Sanderson J, Stevens J, Goka E, Rawdin A, Sadler S, Wong R, Campbell F, Stevenson M , Strong M et al (2016) A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment, 20(78), 1-406. View this article in WRRO
• Kaltenthaler E, Cooper K, Pandor A, Martyn-St James M, Chatters R & Wong R (2016) The use of rapid review methods in health technology assessments: 3 case studies. BMC Medical Research Methodology, 16(1). View this article in WRRO
• Sanderson J, Martyn-St James M, Stevens J, Goka E, Wong R, Campbell F, Selby P, Gittoes N & Davis S (2016) Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis. Bone, 89, 52-58. View this article in WRRO
• Stevenson M, Pandor A, Martyn-St James M, Rafia R, Uttley L, Stevens J, Sanderson J, Wong R, Perkins GD, McMullan R & Dark P (2016) Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.. Health Technology Assessment, 20(46), 1-246. View this article in WRRO
• Chatters R, Cooper K, Day E, Knight M, Lagundoye O, Wong R & Kaltenthaler E (2016) Psychological and psychosocial interventions for cannabis cessation in adults: A systematic review. Addiction Research and Theory, 24(2), 93-110. View this article in WRRO
• Essat M, Tappenden P, Ren S, Bessey A, Archer R, Wong R, Lobo A & Hoque S (2016) Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 34(3), 245-257. View this article in WRRO
• Gomersal T, Harnan S, Essat M, Tappenden P, Wong R, Lawson R, Pavord I & Everard ML (2016) A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthma. Pediatric Pulmonology, 51(3), 316-328.
• Essat M, Harnan S, Gomersall T, Tappenden P, Wong R, Pavord I, Lawson R & Everard M (2016) Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. European Respiratory Society, 47(3), 751-768. View this article in WRRO
• Cooper K, Chatters R, Kaltenthaler E & Wong R (2015) Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report. Health Technology Assessment, 19(56), 1-130. View this article in WRRO
• Pandor A, Kaltenthaler E, Higgins A, Lorimer K, Smith S, Wylie K & Wong R (2015) Sexual health risk reduction interventions for people with severe mental illness: a systematic review. BMC Public Health, 15(1).
• Simpson EL, Davis S, Thokala P, Breeze PR, Bryden P & Wong R (2015) Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. PharmacoEconomics, 33(11), 1187-1194. View this article in WRRO
• Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, Pavord I, Everard M & Lawson R (2015) Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and Nobreath. Health Technology Assessment, 19(82), 1-330. View this article in WRRO
• Latimer NR, Carroll C, Wong R, Tappenden P, Venning MC & Luqmani R (2014) Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal. PharmacoEconomics, 32(12), 1171-1183. View this article in WRRO
• Poku E, Rathbone J, Everson-Hock E, Essat M, Wong R, Pandor A & Wailoo A (2014) The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review. BMJ Open, 4. View this article in WRRO
• Kaltenthaler E, Pandor A & Wong R (2014) The effectiveness of sexual health interventions for people with severe mental illness: a systematic review.. Health Technol Assess, 18(1), 1-74. View this article in WRRO
• Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, Wong R, Brennan A & Fitzgerald P (2013) Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.. Health Technol Assess, 17(32), 1-vi. View this article in WRRO
• Wong R, Paisley S & Carroll C (2013) Assessing searches in NICE single technology appraisals: practice and checklist.. Int J Technol Assess Health Care, 29(3), 315-322.
• Pandor A, Gomersall T, Stevens JW, Wang J, Al-Mohammad A, Bakhai A, Cleland JGF, Cowie MR & Wong R (2013) Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis.. Heart, 99(23), 1717-1726.
• Thokala P, Baalbaki H, Brennan A, Pandor A, Stevens JW, Gomersall T, Wang J, Bakhai A, Al-Mohammad A, Cleland J , Cowie MR et al (2013) Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs.. BMJ Open, 3(9), e003250. View this article in WRRO
• Tappenden P, Campbell F, Rawdin A, Wong R & Kalita N (2012) The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.. Health Technol Assess, 16(20), 1-72.
• Stevenson M, Lloyd-Jones M, Morgan MY & Wong R (2012) Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 16(4), 1-174.
• Boote J, Wong R & Booth A (2012) 'Talking the talk or walking the walk?' A bibliometric review of the literature on public involvement in health research published between 1995 and 2009. Health Expectations.
• Squires H, Simpson E, Meng Y, Harnan S, Stevens J, Wong R, Thomas S, Michaels J & Stansby G (2011) A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.. Health Technol Assess, 15(40), 1-210.
• Wong R, Allen FH & Willett P (2010) The scientific impact of the Cambridge Structural Database: a citation-based study. J APPL CRYSTALLOGR, 43, 811-824. View this article in WRRO

Website content

• Pandor A, Kaltenthaler E, Cooper K, James MM-S & Wong R SelecTing Approaches for Rapid Reviews (STARR) Decision Tool.